151-165 of 831
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
On the Frontlines of CIDPPrioritizing Patient-Centered, Multidisciplinary Care in CIDP
Andrew G. Lee, MD
Ashley Baker, MSN, PMHNP
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
On the Frontlines of CIDPIdentifying CIDP: A Guide to Risk Profiles and Clinical Presentation
Nicolas Dubuisson, MD
Ryan Quigley
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Kaitlin Batley, MD
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
Kaitlin Batley, MD
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiersSymptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Christopher A. Scheiner, MD, PhD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiersExploring Timing in MS Therapy: Real-World Outcomes of Fumarates
- advertisement
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiersManaging MS in Older Adults: Top 5 Clinical Considerations
Yinan Zhang, MD
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
On the Frontlines of CIDPEmpowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Danielle Minetti
Ryan Quigley
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
On the Frontlines of CIDPNew Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Chafic Karam, MD
Ryan Quigley
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiersUpdates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Richard Nowak, MD, MS
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiersInnovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
Riley Bove, MD, MMSc
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiersHow Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
John A. Morren, MD, FAAN, FAANEM
- advertisement
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiersManaging MS in Women: How to Guide Patients Through Pregnancy and Menopause
Riley Bove, MD, MMSc
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
NeuroFrontiersEmerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
Ahmed Abdelhak, MD
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiersAnti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
